Handelsbanken Fonder’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Handelsbanken Fonder’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,146	Closed	-$27K	–	1623
2023 Q1	$27K	Hold	15,146	–	–	﹤0.01%	1560
2022 Q4	$48K	Buy	+15,146	New	+$58.8K	﹤0.01%	1549
2022 Q3	–	Sell	-28,246	Closed	-$117K	–	1591
2022 Q2	$117K	Sell	28,246 -7,000	-20%	-$30.3K	﹤0.01%	1569
2022 Q1	$205K	Hold	35,246	–	–	﹤0.01%	1628
2021 Q4	$264K	Hold	35,246	–	–	﹤0.01%	1643
2021 Q3	$318K	Hold	35,246	–	–	﹤0.01%	1573
2021 Q2	$422K	Buy	35,246 +17,800	+102%	+$202K	﹤0.01%	1499
2021 Q1	$219K	Hold	17,446	–	–	﹤0.01%	1528
2020 Q4	$272K	Hold	17,446	–	–	﹤0.01%	1446
2020 Q3	$165K	Hold	17,446	–	–	﹤0.01%	1413
2020 Q2	$156K	Buy	+17,446	New	+$162K	﹤0.01%	1404
2019 Q2	–	Sell	-95,000	Closed	-$906K	–	193
2019 Q1	$906K	Hold	95,000	–	–	0.02%	173
2018 Q4	$1.09M	Sell	95,000 -450,000	-83%	-$5.59M	0.02%	159
2018 Q3	$9.24M	Buy	545,000 +188,000	+53%	+$2.86M	0.17%	131
2018 Q2	$5.07M	Buy	+357,000	New	+$5.93M	0.1%	145

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Handelsbanken Fonder's SGMO Position: Q2 2023 in Review

Handelsbanken Fonder sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 15,146 shares — an estimated $27K sold.

Handelsbanken Fonder first reported a position in SGMO in Q2 2018 and held it in 15 quarters. The position peaked at $9.24M in Q3 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

Handelsbanken Fonder reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 15,146 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $27K.
Handelsbanken Fonder first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 15 quarters.
Handelsbanken Fonder's SANGAMO THERAPEUTICS INC position peaked at $9.24M in Q3 2018.
152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.